![Comparative Biodistribution of the Radiohalogenated (Br, I and At) Antibody A33. Implications for
<i>In Vivo</i>
Dosimetry.]()
Comparative Biodistribution of the Radiohalogenated (Br, I and At) Antibody A33. Implications for
<i>In Vivo</i>
Dosimetry.Orlova, Anna; Höglund, Johanna; Lubberink, Mark; Lebeda, Ondrej; Gedda, Lars; Lundqvist, Hans; Tolmachev, Vladimir; Sundin, Anders · Cancer Biotherapy & Radiopharmaceuticals · 2002